A permutation test based on the restricted mean survival time for comparison of net survival distributions in non-proportional excess hazard settings

被引:6
|
作者
Wolski, Anna [1 ]
Graffeo, Nathalie [1 ,2 ,3 ]
Giorgi, Roch [4 ]
机构
[1] Aix Marseille Univ, INSERM, IRD, SESSTIM, Marseille, France
[2] St Louis Hosp, INSERMU1153, Statist & Epidemiol Res Ctr, Sorbonne Paris Cite,CRESS ECSTRRA Team, Paris, France
[3] Paris Diderot Univ, Paris, France
[4] Aix Marseille Univ, Hop Timone, AP HM, INSERM,IRD,SESSTIM,BioSTIC Biostat & Technol Info, Marseille, France
关键词
Survival analysis; net survival; restricted mean survival time; excess hazard; non-proportional hazards; hypothesis testing; cancer; life benefit;
D O I
10.1177/0962280219870217
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Net survival is used in epidemiological studies to assess excess mortality due to a given disease when causes of death are unreliable. By correcting for the general population mortality, it allows comparisons between regions or periods and thus evaluation of health policies. The Pohar-Perme non-parametric estimator of net survival has been recently proposed, soon followed by an appropriate log-rank-type test. However, log-rank tests are known to be under-optimal in non-proportional settings (e.g. crossing of the hazard functions). In classical survival analysis, one solution is to compare the restricted mean survival times. A difference in restricted mean survival time represents a life benefit or loss over the studied period. In the present article the restricted mean net survival time was used to derive a specific test statistic to compare net survivals in proportional and non-proportional hazards settings. The new test was generalized to more than two groups and to stratified analysis. The test performance was assessed on simulation study, compared to the log-rank-type test, and its use illustrated on a population-based colorectal cancer registry. The new test for net survival comparisons proved robust to non-proportionality and well-performing in proportional hazards situations. Furthermore, it is also suited to the classical survival framework.
引用
收藏
页码:1612 / 1623
页数:12
相关论文
共 50 条
  • [1] A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates
    Charvat, Hadrien
    Remontet, Laurent
    Bossard, Nadine
    Roche, Laurent
    Dejardin, Olivier
    Rachet, Bernard
    Launoy, Guy
    Belot, Aurelien
    [J]. STATISTICS IN MEDICINE, 2016, 35 (18) : 3066 - 3084
  • [2] THE IMPLICATIONS OF NON-PROPORTIONAL HAZARDS FOR THE MEASUREMENT OF SURVIVAL BENEFIT IN HEALTH TECHNOLOGY ASSESSMENT: CURRENT APPROACHES AND THE ROLE OF RESTRICTED MEAN SURVIVAL TIME
    Monnickendam, G.
    McKendrick, J.
    Zhu, M.
    Su, Y.
    [J]. HAEMATOLOGICA, 2017, 102 : 603 - 603
  • [3] ANALYSIS OF SURVIVAL-DATA WITH NON-PROPORTIONAL HAZARD FUNCTIONS
    STABLEIN, DM
    CARTER, WH
    NOVAK, JW
    [J]. CONTROLLED CLINICAL TRIALS, 1981, 2 (02): : 149 - 159
  • [4] Modelling non-proportional hazard for survival data with different systematic components
    Fábio Prataviera
    Selene M. C. Loibel
    Kathleen F. Grego
    Edwin M. M. Ortega
    Gauss M. Cordeiro
    [J]. Environmental and Ecological Statistics, 2020, 27 : 467 - 489
  • [5] Modelling non-proportional hazard for survival data with different systematic components
    Prataviera, Fabio
    Loibel, Selene M. C.
    Grego, Kathleen F.
    Ortega, Edwin M. M.
    Cordeiro, Gauss M.
    [J]. ENVIRONMENTAL AND ECOLOGICAL STATISTICS, 2020, 27 (03) : 467 - 489
  • [6] USE OF RESTRICTED MEAN SURVIVAL TIME IN THE PRESENCE OF NON-PROPORTIONAL HAZARDS AS AN ALTERNATIVE MEASURE OF TREATMENT BENEFIT IN COST-EFFECTIVENESS ANALYSES
    Tavernier, R.
    Gaugain, L.
    Cawston, H.
    Lueza, B.
    Welty, M.
    Gauthier, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S57 - S57
  • [7] Omnibus test for restricted mean survival time based on influence function
    Gu, Jiaqi
    Fan, Yiwei
    Yin, Guosheng
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2023, 32 (06) : 1082 - 1099
  • [8] Comparison of the restricted mean survival time with the hazard ratio in superiority trials with a time-to-event end point
    Huang, Bo
    Kuan, Pei-Fen
    [J]. PHARMACEUTICAL STATISTICS, 2018, 17 (03) : 202 - 213
  • [9] Analysis of survival data from trials with non-proportional hazards: an empirical comparison of methods
    Patrick Royston
    Yinghui Wei
    Jayne Tierney
    Mahesh Parmar
    [J]. Trials, 14 (Suppl 1)